Publikationen, an denen er mitarbeitet NORBERTO ORTEGO CENTENO (26)

2016

  1. Tocilizumab as an Adjuvant Therapy for Hemophagocytic Lymphohistiocytosis Associated with Visceral Leishmaniasis

    American Journal of Therapeutics, Vol. 23, Núm. 5, pp. e1193-e1196

2013

  1. Increased CD38 expression in T cells and circulating anti-CD38 IgG autoantibodies differentially correlate with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients

    Cytokine, Vol. 62, Núm. 2, pp. 232-243

2012

  1. Altered AKT1 and MAPK1 gene expression on peripheral blood mononuclear cells and correlation with T-helper-transcription factors in Systemic Lupus Erythematosus patients

    Mediators of Inflammation, Vol. 2012

  2. Increased expression and phosphorylation of the two S100A9 isoforms in mononuclear cells from patients with systemic lupus erythematosus: A proteomic signature for circulating low-density granulocytes

    Journal of Proteomics, Vol. 75, Núm. 6, pp. 1778-1791

2009

  1. Differential protein expression in peripheral blood mononuclear cells (PBMCs) on patients withd systemic lupus erythematosus (SLE)

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 3, pp. 116-116

  2. Identification of a new putative functional IL18 gene variant through an association study in systemic lupus erythematosus

    Human Molecular Genetics, Vol. 18, Núm. 19, pp. 3739-3748

  3. Investigation of TLR5 and TLR7 as candidate genes for susceptibility to systemic lupus erythematosus

    Clinical and Experimental Rheumatology

  4. Kallikrein genes are associated with lupus and glomerular basement membrane-specific antibody-induced nephritis in mice and humans

    Journal of Clinical Investigation, Vol. 119, Núm. 4, pp. 911-923

  5. No evidence for genetic association of interferon regulatory factor 3 in systemic lupus erythematosus

    Lupus, Vol. 18, Núm. 3, pp. 230-234

  6. STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk

    Annals of the Rheumatic Diseases, Vol. 68, Núm. 11, pp. 1746-1753

2008

  1. Expresión diferencial de las cuatro isoformas de la proteína de unión a calcio S100A9 (Calgranulina B) en células mononucleares de sangre periférica de pacientes con lupus eritematoso sistémico respecto a controlos sanos

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 1, pp. 51-52

  2. Study of two polymorphisms of the MHC2TA gene with systemic lupus erythematosus [1]

    Rheumatology

2007

  1. Analysis of interleukin-23 receptor (IL23R) gene polymorphisms in systemic lupus erythematosus

    Tissue Antigens, Vol. 70, Núm. 3, pp. 233-237

  2. Association of a CD24 gene polymorphism with susceptibility to systemic lupus erythematosus

    Arthritis and Rheumatism, Vol. 56, Núm. 9, pp. 3080-3086

  3. MYO9B gene polymorphisms are associated with autoimmune diseases in Spanish population

    Human Immunology, Vol. 68, Núm. 7, pp. 610-615

  4. Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus

    Arthritis and Rheumatism, Vol. 56, Núm. 4, pp. 1234-1241

2006

  1. Arteritis de Takayasu asociada a colitis ulcerosa

    Medicina Clinica

  2. Evidence of association of macrophage migration inhibitory factor gene polymorphisms with systemic lupus erythematosus

    Genes and Immunity, Vol. 7, Núm. 5, pp. 433-436

  3. Increased association of CD38 with lipid rafts in T cells from patients with systemic lupus erythematosus and in activated normal T cells

    Molecular Immunology, Vol. 43, Núm. 7, pp. 1029-1039

  4. No primary association of MICA polymorphism with systemic lupus erythematosus

    Rheumatology, Vol. 45, Núm. 9, pp. 1096-1100